Alnylam Pharmaceuticals Inc (ALNY) — Technical state
As of 2026-11-04 — re-computed nightly across the coverage universe. Closelooknet diary readings, not advice.
The Closelooknet read
- Signal: Downtrend stack — Trades -30.5% vs the 50-day and -43% vs the 200-day average, 66.4% below the 52-week high and +3.3% off the 52-week low. Computed from daily closes. (as of 2026-11-04)
- Trend: Alnylam Pharmaceuticals Inc trades 30.5% below its 50-day and 43.0% below its 200-day moving average. (as of 2026-11-04)
Alnylam develops medicines built on RNA interference, a method that silences disease-causing genes rather than targeting the proteins they make. It sells treatments for hereditary amyloidosis, high cholesterol, haemophilia, acute porphyria and a rare kidney disorder, and runs a pipeline of experimental drugs through several trial phases.
The full read — the desk's view, the earnings record, peers and the company snapshot — is on the ALNY overview. Research diary readings, not advice.
Trades -30.5% vs the 50-day and -43% vs the 200-day average, 66.4% below the 52-week high and +3.3% off the 52-week low. Computed from daily closes.
The moving-average stack
- vs 20-day-24.1%
- vs 50-day-30.5%
- vs 200-day-43%
- 52-week band66.4% off the high · +3.3% off the low
- Streak2 consecutive up sessions
- 50-day crossprice crossed down through the 50-day 24 sessions ago
- Stochastic%K 6.1 · %D 3.1 · bull cross
Continue: the ALNY chart & overview · the signal board
FAQ · from the current data · as of 2026-11-04
Quick answers
What is the current Closelooknet signal on ALNY?
Downtrend stack — Trades -30.5% vs the 50-day and -43% vs the 200-day average, 66.4% below the 52-week high and +3.3% off the 52-week low. Computed from daily closes. As of 2026-11-04; the signal board re-computes across the coverage universe nightly. A research diary reading, not advice.
Is ALNY above its 50-day and 200-day moving averages?
As of 2026-11-04, Alnylam Pharmaceuticals Inc trades -30.5% below its 50-day and -43% below its 200-day average, with the 20-day -24.1% away.
How far is ALNY from its 52-week high?
66.4% below the 52-week high and 3.3% above the 52-week low, as of 2026-11-04.
Related in the Closelooknet universe
then Biotechnology. Scored names rank on their Closelooknet score; names without one rank on trend state — above or below their 50- and 200-day averages — never on a score they do not carry.
- HALO Halozyme Therapeutics Incindustry
- ONC BeOne Medicines AGindustry
- ARGX.BR Argen-Xindustry
- UCB.BR UCB SAindustry
- ARGX argenx NV ADRindustry
- REGN Regeneron Pharmaceuticals Incindustry
- REPL Replimune Group Incindustry
- KOD Kodiak Sciences Incindustry
- MRNA Moderna Incindustry
- XNCR Xencor Incindustry
- VRDN Viridian Therapeutics Incindustry
- ARQT Arcutis Biotherapeutics Incindustry
- SEPN Septerna, Inc. Common Stockindustry
- MAZE Maze Therapeutics, Inc. Common Stockindustry
- EXEL Exelixis Incindustry
- DNA Ginkgo Bioworks Holdingsindustry
- KYMR Kymera Therapeutics Incindustry
- IRON Disc Medicine Inc.industry
- MEDCL.PA Medincell SAindustry
- LEGN Legend Biotech Corpindustry